Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

124 ARTÍCULOS , VIENDO DEL 91 AL 105

Advances in MRI biomarkers for the diagnosis of Alzheimer's disease

Kehoe EG, McNulty JP, Mullins PG, Bokde AL.

Biomark Med. 2014;8(9):1151-69. doi: 10.2217/bmm.14.42.

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians

Asih PR, Chatterjee P, Verdile G, Gupta VB, Trengove RD, Martins RN.

Neurodegener Dis Manag. 2014;4(5):363-78. doi: 10.2217/nmt.14.29.

Focus on GABA(A) receptor function. A comparative analysis of in vivo imaging studies in neuropsychiatric disorders

Nikolaus S, Hautzel H, Müller HW.

Nuklearmedizin. 2014;53(6):227-37. doi: 10.3413/Nukmed-0647-14-03. Epub 2014 Aug 27.

[Diagnosis and treatment of dementia: overview]

Furukawa K, Ishiki A, Tomita N, Arai H.

Rinsho Shinkeigaku. 2014;54(12):1171-3. doi: 10.5692/clinicalneurol.54.1171.

A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations

Roussotte FF, Jahanshad N, Hibar DP, Sowell ER, Kohannim O, Barysheva M, Hansell NK, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Wright MJ, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; ADNI.

Hum Brain Mapp. 2014 Apr;35(4):1226-36. doi: 10.1002/hbm.22247. Epub 2013 Feb 21.

Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease

Orta-Salazar E, Cuellar-Lemus CA, Díaz-Cintra S, Feria-Velasco AI.

Neurologia. 2014 Oct;29(8):497-503. doi: 10.1016/j.nrl.2012.10.007. Epub 2013 Feb 22.

Comparison between clinical diagnosis and CSF biomarkers of Alzheimer disease in elderly patients with late onset psychosis: Helsinki Old Age Psychosis Study (HOPS)

Seppälä TT, Louhija UM, Appelberg B, Herukka SK, Juva K.

Am J Geriatr Psychiatry. 2014 Sep;22(9):908-16. doi: 10.1016/j.jagp.2012.08.020. Epub 2013 Apr 15.

Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease

Blennow K, Hampel H, Zetterberg H.

Neuropsychopharmacology. 2014 Jan;39(1):189-201. doi: 10.1038/npp.2013.154. Epub 2013 Jun 25.

Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease

Fiolaki A, Tsamis KI, Milionis HJ, Kyritsis AP, Kosmidou M, Giannopoulos S.

Int J Neurosci. 2014 Jan;124(1):1-11. doi: 10.3109/00207454.2013.821988. Epub 2013 Aug 6.

CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease

Lista S, Garaci FG, Ewers M, Teipel S, Zetterberg H, Blennow K, Hampel H.

Alzheimers Dement. 2014 May;10(3):381-92. doi: 10.1016/j.jalz.2013.04.506. Epub 2013 Jul 11.

The future of blood-based biomarkers for Alzheimer's disease

Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, Lönneborg A, Wyss-Coray T, Soares H, Bazenet C, Sjögren M, Hu W, Lovestone S, Karsdal MA, Weiner MW; Blood-Based Biomarker Interest Group.

Alzheimers Dement. 2014 Jan;10(1):115-31. doi: 10.1016/j.jalz.2013.01.013. Epub 2013 Jul 11.

Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum

Donovan NJ, Wadsworth LP, Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA; Alzheimer Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1168-79. doi: 10.1016/j.jagp.2013.03.006. Epub 2013 Jul 24.

Reduced frequency of T lymphocytes expressing CTLA-4 in frontotemporal dementia compared to Alzheimer's disease

Santos RR, Torres KC, Lima GS, Fiamoncini CM, Mapa FC, Pereira PA, Rezende VB, Martins LC, Bicalho MA, Moraes EN, Reis HJ, Teixeira AL, Romano-Silva MA.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:1-5. doi: 10.1016/j.pnpbp.2013.06.019. Epub 2013 Jul 25.

Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology

Obulesu M, Jhansilakshmi M.

Int J Neurosci. 2014 Apr;124(4):227-35. doi: 10.3109/00207454.2013.831852. Epub 2013 Sep 12.

Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example

Leoutsakos JM, Bartlett AL, Forrester SN, Lyketsos CG.

Alzheimers Dement. 2014 Mar;10(2):152-61. doi: 10.1016/j.jalz.2013.05.1776. Epub 2013 Aug 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias